Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Benchmarks provide a reference point to gauge portfolio performance and risk. This intro explains how comparing returns against a relevant benchmark clarifies decisions and helps align goals.
22,975 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Solana’s SOL is hovering near a key $95 zone as traders watch for a breakout. Fresh data show rising volumes and a ti...
The Department of Justice has released additional Epstein-related records that include unverified accusations about P...
Oil markets are dictating Bitcoin moves as geopolitical risk deepens, outpacing CPI and ETF factors. Traders say the ...
Celink’s Ryan LaRose outlines how reverse mortgage servicing is shaped by scale pressures and growth limits, driven b...
Ford reveals a heavy Q4 loss tied to Model e impairments, renewing Reddit-driven skepticism about its EV turnaround a...
In March 2026, smart japan investors choosing hedged exposure via DXJ are gaining ground as currency moves and reform...
Micron Technology led a Tuesday rally in the memory sector, with peers posting solid gains as a new AMAT collaboratio...
House Democrats unveiled a pair of bills aimed at banning event contracts on Polymarket US and other platforms. The m...
RZC Investments, the Walton family–funded private equity arm, has paused new investments while it reevaluates its fun...
Oil pushes toward $100 a barrel as Bitcoin struggles to extend its rally, with surges near $100 stalling the crypto b...
Solana is trading in a narrow band as a key indicator points to a potential breakout. Analysts caution that volatilit...